Oncological, cognitive, and employment outcomes in a series of patients with IDH-mutated glioma resected following neoadjuvant chemotherapy.
Marco BursiClaudia RizzoMarion BarberisIsabelle PoissonJacqueline Lehman-CheHoma Adle-BiassetteSébastien FroelichEmmanuel MandonnetPublished in: Acta neurochirurgica (2023)
Neoadjuvant chemotherapy followed by maximal safe resection can be offered to patients affected by IDH-mutated gliomas for whom upfront surgery would be inadequate. More studies are necessary given the limited size of our sample.
Keyphrases
- neoadjuvant chemotherapy
- lymph node
- locally advanced
- sentinel lymph node
- end stage renal disease
- rectal cancer
- wild type
- low grade
- chronic kidney disease
- ejection fraction
- newly diagnosed
- minimally invasive
- high grade
- squamous cell carcinoma
- coronary artery bypass
- heart rate
- radiation therapy
- acute coronary syndrome
- metabolic syndrome
- early stage
- adipose tissue
- patient reported outcomes
- radical prostatectomy
- atrial fibrillation
- insulin resistance